Diag2Tec provides tailored genomic and multi-omics services designed to address specific scientific questions and study objectives. Leveraging advanced technologies such as whole exome sequencing, ChIP-seq, and miRNA profiling, combined with deep-learning algorithms, we generate high-resolution datasets to decode disease complexity and therapeutic responses. Our flexible approach enables the design of customized workflows aligned with each customer’s development strategy.
Diag2Tec provides tailored genomic and multi-omics services designed to address specific scientific questions and study objectives. Leveraging advanced technologies such as whole exome sequencing, ChIP-seq, and miRNA profiling, combined with deep-learning algorithms, we generate high-resolution datasets to decode disease complexity and therapeutic responses. Our flexible approach enables the design of customized workflows aligned with each customer’s development strategy.
Advanced Analytical Capabilities
Our platform supports:
- Identification of mutations using RNA Sequencing and Whole Exome Sequencing
- Identification of epigenetic alterations using ChIP-Seq and ATAC-Seq
- MicroRNA and Long Non-Coding RNA profiling
- Deconvolution of immune cells
AI-Driven Multi-Omics Integration
We integrate diverse data layers using advanced computational and machine learning approaches to deliver predictive and actionable insights:
- Integration of genomic, transcriptomic, and epigenomic data with biological assay results and clinical data
- Identification of key molecular drivers and regulatory networks
- Definition of novel molecular patient subgroups
- Development and validation of predictive models and scoring systems using public and proprietary datasets
Deliverables
High-quality, decision-ready data packages including comprehensive reports, as well as raw, quality-controlled, and processed datasets. Our analyses support data-driven decision-making and precision medicine approaches in preclinical and translational research.